PapersPMID:29864430

Oral Glucosamine Hydrochloride Combined With Hyaluronate Sodium Intra-Articular Injection for Temporomandibular Joint Osteoarthritis: A Double-Blind Randomized Controlled Trial.

Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons2018The record ↗

01 · finding: 1
02 · compound: 1
03 · endpoint: 1
04 · null: 0

glucosamine

PMID:29864430 · 1 finding from this paper, in bands by direction at evidence strength

What it reported

How to read these marks

What moved

1 finding

glucosamine — decreases visual analogue scale pain intensity
Evidence strength: very limited.Finding
“For pain intensity, group A showed obviously lower visual analog scale scores than group B at month 6 (20.6 vs 29.2 mm; P = .007) and month 12 (17.4 vs 28.6 mm; P = .001).”
Quoted verbatim from Oral Glucosamine Hydrochloride Combined With Hyaluronate Sodium Intra-Articular Injection for Temporomandibular Joint Osteoarthritis: A Double-Blind Randomized Controlled Trial..
Study

RCT
Dose

oral glucosamine hydrochloride (1.44 g/day) for 3 months
Population

adults with temporomandibular joint osteoarthritis; both groups also received hyaluronate sodium intra-articular injections
Oral Glucosamine Hydrochloride Combined With Hyaluronate Sodium Intra-Articular Injection for Temporomandibular Joint Osteoarthritis: A Double-Blind Randomized Controlled Trial.2018PMID:2986443010.1016/j.joms.2018.04.031Permalink

Study record

Read under: glucosamine

Design: randomised controlled trial
Species: human
Population: adults with temporomandibular joint osteoarthritis; both groups also received hyaluronate sodium intra-articular injections
Participants: not recorded
Comparator: not stated in the paper
Duration: not recorded
Endpoints: 3
Record: extracted
Readings recorded: 2